Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hepatitis C prevalence reaches 2% of US population:

This article was originally published in Clinica

Executive Summary

Hepatitis C has become the most chronic blood borne infection in the US with prevalence reaching 1.8% of the population, according to the country's third National Health and Nutrition Examination Survey. The survey, reported in the August 19 issue of the New England Journal of Medicine, indicates that 3.9 million people have hepatitis C infection with almost 70% of this figure chronically infected. The strongest factors associated with infection are illegal drug use and high-risk sexual behaviour. Between 8,000 and 10,000 deaths occur annually from liver complications associated with hepatitis C, says the survey.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT079390

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel